Major shareholder announcement – Invesco Ltd.
March 18 2024 - 7:25AM
Major shareholder announcement – Invesco Ltd.
ANNOUNCEMENT NO. 256
Major shareholder announcement
Major shareholder announcement – Invesco
Ltd.
Pursuant to Section 30 of the Danish Capital
Markets Act, it is hereby announced that Invesco Ltd. has informed
ChemoMetec A/S that Invesco Ltd. on 13 March 2024, increased its
holding of voting rights to above 5% of the total voting rights in
ChemoMetec A/S, and that the holding thus exceeds the 5 per cent
limit in section 38 of the Capital Markets Act.
Additional information
Niels Høy Nielsen, CFOTelephone (+45) 2551 8724
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets
instruments for cell counting and a wide range of other
measurements. ChemoMetec’s instruments are marketed to the
pharmaceutical, biotech and agricultural industries worldwide.
ChemoMetec’s customers include some of the world’s leading
pharmaceutical companies, such as Novartis, Novo Nordisk, H.
Lundbeck, Merck, AstraZeneca and Johnson & Johnson.
ChemoMetec was founded in 1997 and is listed on
Nasdaq OMX Copenhagen. For more information, go to
www.chemometec.com
Chemometec AS (TG:CHY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Chemometec AS (TG:CHY)
Historical Stock Chart
From Jul 2023 to Jul 2024